Athira Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Athira Pharma generated cash of -$100,753,000, which is less than the previous year. Cash used in financing activities reached the amount of $493,000 last year. Net change in cash is therefore -$5,171,000.
Cash Flow
| 2018 | -4.48M | 2.00M | 1.46M |
|---|---|---|---|
| 2019 | -3.71M | 1.50M | 946K |
| 2020 | -24.11M | -210.06M | 292.75M |
| 2021 | -43.09M | -4.07M | 97.08M |
| 2022 | -72.46M | 57.66M | 654K |
| 2023 | -100.75M | 95.08M | 493K |
ATHA Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 96.38M | 110.53M | 60.62M | 2.05M | 3.31M | 4.32M |
Operating activities | ||||||
Net income | -117.67M | -95.63M | -54.85M | -19.95M | -5.16M | -5.09M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 969K | 845K | 479K | 251K | 2 | 0 |
Stock-based compensation expense | 10.62M | 10.60M | 4.62M | 633K | 253K | 0 |
| Deferred income tax benefit | 10.62M | 10.60M | 4.62M | 633K | 253K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 1.10M | -1.03M | -1.3K | -23 | 0 |
Inventories | 0 | -1.10M | 1.03M | 1.3K | 23 | 0 |
Accounts payable | 7.36M | 2.10M | 5.15M | 2.60M | 701K | 0 |
Cash generated by operating activities | -100.75M | -72.46M | -43.09M | -24.11M | -3.71M | -4.48M |
Investing activities | ||||||
Purchases Of Investments | -27.67M | -95.28M | -299.19M | -226.83M | -995K | -5.25M |
Investments In Property Plant And Equipment | -304K | -1.14M | -1.57M | -2.32M | 0 | 0 |
Acquisitions Net | 0 | -58.80K | 2.50K | 0 | 0 | 0 |
Cash generated by investing activities | 95.08M | 57.66M | -4.07M | -210.06M | 1.50M | 2.00M |
Financing activities | ||||||
Common Stock Issued | 493K | 654K | 96.76M | 208.51M | 72K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -1.66M | 874K | 0 |
Cash used in financing activities | 493K | 654K | 97.08M | 292.75M | 946K | 1.46M |
Net Change In Cash | -5.17M | -14.15M | 49.91M | 58.56M | -1.26M | -1.01M |
Cash at end of period | 91.21M | 96.38M | 110.53M | 60.62M | 2.05M | 3.31M |
| Data source | Data source | Data source | Data source |